Synthetic biology funds back companies programming biology to create new materials, medicines, and chemicals. From engineered microbes to cell-free systems, these investors fuel the transition from petrochemical to biological manufacturing.
Showing 41-60 of 128 funds
Berlin, Germany
San Francisco, United States
San Francisco, United States
San Francisco, United States